Cargando…

BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity

Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldwide. Different strains of T. cruzi present specific genotypic and phenotypic characteristics that affect the host–pathogen interactions, and thus, the parasite has been classified into six groups (TcI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Bianca L., Ferreira, Éden R., de Brito, Marlon V., Salu, Bruno R., Oliva, Maria L. V., Mortara, Renato A., Orikaza, Cristina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890190/
https://www.ncbi.nlm.nih.gov/pubmed/29662478
http://dx.doi.org/10.3389/fmicb.2018.00553
_version_ 1783312823068131328
author Ferreira, Bianca L.
Ferreira, Éden R.
de Brito, Marlon V.
Salu, Bruno R.
Oliva, Maria L. V.
Mortara, Renato A.
Orikaza, Cristina M.
author_facet Ferreira, Bianca L.
Ferreira, Éden R.
de Brito, Marlon V.
Salu, Bruno R.
Oliva, Maria L. V.
Mortara, Renato A.
Orikaza, Cristina M.
author_sort Ferreira, Bianca L.
collection PubMed
description Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldwide. Different strains of T. cruzi present specific genotypic and phenotypic characteristics that affect the host–pathogen interactions, and thus, the parasite has been classified into six groups (TcI to TcVI). T. cruzi infection presents two clinical phases, acute and chronic, both with distinct characteristics and important participation by the immune system. However, the specific contributions of parasite and host factors in the disease phases are not yet fully understood. The murine model for Chagas’ disease is well-established and reproduces important features of the human infection, providing an experimental basis for the study of host lineages and parasite strains. Thus, we evaluated acute and chronic infection by the G (TcI) and CL (TcVI) strains of T. cruzi, which have distinct tropisms and infectivity, in two inbred mice lineages (C57BL/6 and BALB/c) that display variable degrees of susceptibility to different T. cruzi strains. Analysis of the parasite loads in host tissues by qPCR showed that CL strain established an infection faster than the G strain; at the same time, the response in BALB/c mice, although diverse in terms of cytokine secretion, was initiated earlier than that in C57BL/6 mice. At the parasitemia peak in the acute phase, we observed, either by confocal microscopy or by qPCR, that the infection was disseminated in all groups analyzed, with some differences concerning parasite tropism; at this point, all animals responded to infection by increasing the serum concentrations of cytokines. However, BALB/c mice seemed to better regulate the immune response than C57BL/6 mice. Indeed, in the chronic phase, C57BL/6 mice still presented exacerbated cytokine and chemokine responses. In summary, our results indicate that in these experimental models, the deregulation of immune response that is typical of chronic Chagas’ disease may be due to control loss over pro- and anti-inflammatory cytokines early in the acute phase of the disease, depending primarily on the host background rather than the parasite strain.
format Online
Article
Text
id pubmed-5890190
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58901902018-04-16 BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity Ferreira, Bianca L. Ferreira, Éden R. de Brito, Marlon V. Salu, Bruno R. Oliva, Maria L. V. Mortara, Renato A. Orikaza, Cristina M. Front Microbiol Microbiology Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldwide. Different strains of T. cruzi present specific genotypic and phenotypic characteristics that affect the host–pathogen interactions, and thus, the parasite has been classified into six groups (TcI to TcVI). T. cruzi infection presents two clinical phases, acute and chronic, both with distinct characteristics and important participation by the immune system. However, the specific contributions of parasite and host factors in the disease phases are not yet fully understood. The murine model for Chagas’ disease is well-established and reproduces important features of the human infection, providing an experimental basis for the study of host lineages and parasite strains. Thus, we evaluated acute and chronic infection by the G (TcI) and CL (TcVI) strains of T. cruzi, which have distinct tropisms and infectivity, in two inbred mice lineages (C57BL/6 and BALB/c) that display variable degrees of susceptibility to different T. cruzi strains. Analysis of the parasite loads in host tissues by qPCR showed that CL strain established an infection faster than the G strain; at the same time, the response in BALB/c mice, although diverse in terms of cytokine secretion, was initiated earlier than that in C57BL/6 mice. At the parasitemia peak in the acute phase, we observed, either by confocal microscopy or by qPCR, that the infection was disseminated in all groups analyzed, with some differences concerning parasite tropism; at this point, all animals responded to infection by increasing the serum concentrations of cytokines. However, BALB/c mice seemed to better regulate the immune response than C57BL/6 mice. Indeed, in the chronic phase, C57BL/6 mice still presented exacerbated cytokine and chemokine responses. In summary, our results indicate that in these experimental models, the deregulation of immune response that is typical of chronic Chagas’ disease may be due to control loss over pro- and anti-inflammatory cytokines early in the acute phase of the disease, depending primarily on the host background rather than the parasite strain. Frontiers Media S.A. 2018-03-26 /pmc/articles/PMC5890190/ /pubmed/29662478 http://dx.doi.org/10.3389/fmicb.2018.00553 Text en Copyright © 2018 Ferreira, Ferreira, de Brito, Salu, Oliva, Mortara and Orikaza. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Ferreira, Bianca L.
Ferreira, Éden R.
de Brito, Marlon V.
Salu, Bruno R.
Oliva, Maria L. V.
Mortara, Renato A.
Orikaza, Cristina M.
BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title_full BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title_fullStr BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title_full_unstemmed BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title_short BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
title_sort balb/c and c57bl/6 mice cytokine responses to trypanosoma cruzi infection are independent of parasite strain infectivity
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890190/
https://www.ncbi.nlm.nih.gov/pubmed/29662478
http://dx.doi.org/10.3389/fmicb.2018.00553
work_keys_str_mv AT ferreirabiancal balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT ferreiraedenr balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT debritomarlonv balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT salubrunor balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT olivamarialv balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT mortararenatoa balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity
AT orikazacristinam balbcandc57bl6micecytokineresponsestotrypanosomacruziinfectionareindependentofparasitestraininfectivity